Keyphrases
Corneal Neovascularization
100%
Conjunctival
100%
Aflibercept
100%
Visual Acuity
50%
Cornea
50%
Centricity
50%
Clinically Significant
25%
After Injection
25%
Consecutive Patients
25%
Tertiary Care Hospital
25%
Blood Vessels
25%
Neovascularization
25%
Prospective Clinical Trial
25%
Follow-up Time
25%
Intraocular Pressure
25%
Slit Lamp
25%
Best-corrected Visual Acuity
25%
Systemic Side Effects
25%
Friedman Test
25%
Subjective Improvement
25%
Limbus
25%
Ocular Side Effects
25%
Subconjunctival Injection
25%
Specular Microscopy
25%
Corneal Vascularization
25%
Anti-vascular Endothelial Growth Factor Therapy
25%
Eylea
25%
Anterior Segment Optical Coherence Tomography (AS-OCT)
25%
Pathological Neovascularization
25%
Corneal Pathology
25%
Medicine and Dentistry
Corneal Neovascularization
100%
Aflibercept
100%
Visual Acuity
40%
Adverse Event
20%
Clinical Trial
20%
Vasculotropin
20%
Vascular Bundle
20%
Intraocular Pressure
20%
Optical Coherence Tomography
20%
Best Corrected Visual Acuity
20%
Corneal Limbus
20%
Friedman Test
20%
Specular Microscopy
20%
Subconjunctival Drug Administration
20%
Corneal Pathology
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cornea Neovascularization
100%
Aflibercept
100%
Neovascularization (Pathology)
40%
Clinical Trial
20%
Adverse Event
20%
Vasculotropin
20%